Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03921021
Title Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST